27704563|t|Induction of peptidylarginine deiminase 2 and 3 by dibutyryl cAMP via cAMP-PKA signaling in human astrocytoma U-251MG cells.
27704563|a|Peptidylarginine deiminases (PADs) are posttranslational modification enzymes that citrullinate (deiminate) protein arginine residues in a calcium-dependent manner, yielding citrulline residues. Enzymatic citrullination abolishes positive charges of native protein molecules, inevitably causing significant alterations in their structure and function. Previously, we reported the abnormal accumulation of citrullinated proteins and an increase of PAD2 content in hippocampi of patients with Alzheimer disease. In this study, we investigated PAD expression by using dibutyryl cAMP (dbcAMP) in human astrocytoma U-251MG cells. Under normal culture conditions, PAD2 and PAD3 mRNA expression is detectable with quantitative PCR in U-251MG cells. The addition of dbcAMP in a dose-dependent manner significantly increased this mRNA expression and protein levels. Moreover, PAD enzyme activity also increased significantly and dose-dependently. Furthermore, the expression of PAD2 and PAD3 mRNA was inhibited by the cAMP-dependent PKA inhibitor KT5720, suggesting that such expression of dbcAMP-induced PAD2 and PAD3 mRNA is mediated by the cAMP-PKA signaling pathway in U-251MG cells. This is the first report to document the PAD2 and PAD3 mRNA expression induced by dbcAMP and to attribute the induction of these genes to mediation by the cAMP-PKA signaling pathway in U-251MG cells.   2016 Wiley Periodicals, Inc.
27704563	13	47	peptidylarginine deiminase 2 and 3	Gene	11240;51702
27704563	61	65	cAMP	Gene	820
27704563	70	74	cAMP	Gene	820
27704563	92	97	human	Species	9606
27704563	98	109	astrocytoma	Disease	MESH:D001254
27704563	110	117	U-251MG	CellLine	CVCL:0021
27704563	264	271	calcium	Chemical	MESH:D002118
27704563	299	309	citrulline	Chemical	MESH:D002956
27704563	572	576	PAD2	Gene	11240
27704563	602	610	patients	Species	9606
27704563	616	633	Alzheimer disease	Disease	MESH:D000544
27704563	666	669	PAD	Gene	23569
27704563	700	704	cAMP	Gene	820
27704563	706	712	dbcAMP	Chemical	MESH:D003994
27704563	717	722	human	Species	9606
27704563	723	734	astrocytoma	Disease	MESH:D001254
27704563	735	742	U-251MG	CellLine	CVCL:0021
27704563	783	787	PAD2	Gene	11240
27704563	792	796	PAD3	Gene	51702
27704563	852	859	U-251MG	CellLine	CVCL:0021
27704563	883	889	dbcAMP	Chemical	MESH:D003994
27704563	992	995	PAD	Gene	23569
27704563	1094	1098	PAD2	Gene	11240
27704563	1103	1107	PAD3	Gene	51702
27704563	1134	1138	cAMP	Gene	820
27704563	1163	1169	KT5720	Chemical	MESH:C057416
27704563	1206	1212	dbcAMP	Chemical	MESH:D003994
27704563	1221	1225	PAD2	Gene	11240
27704563	1230	1234	PAD3	Gene	51702
27704563	1259	1263	cAMP	Gene	820
27704563	1289	1296	U-251MG	CellLine	CVCL:0021
27704563	1345	1349	PAD2	Gene	11240
27704563	1354	1358	PAD3	Gene	51702
27704563	1386	1392	dbcAMP	Chemical	MESH:D003994
27704563	1459	1463	cAMP	Gene	820
27704563	1489	1496	U-251MG	CellLine	CVCL:0021
27704563	Association	11240	820
27704563	Positive_Correlation	MESH:D003994	23569
27704563	Positive_Correlation	MESH:D003994	11240
27704563	Association	MESH:C057416	820
27704563	Negative_Correlation	MESH:C057416	51702
27704563	Positive_Correlation	MESH:D000544	11240
27704563	Association	MESH:D003994	820
27704563	Association	MESH:D001254	51702
27704563	Positive_Correlation	MESH:D003994	51702
27704563	Positive_Correlation	51702	820
27704563	Negative_Correlation	MESH:C057416	11240

